Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Center|July 22, 2024
Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)Guangjian Yang, Xuezhi Hao, Jiaqi Hu, et al.
Thoracic Cancer|October 11, 2022
Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practiceYaning Yang, Xin Ai, Haiyan Xu, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH studyGuangjian Yang, Yaning Yang, Runze Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 12, 2013
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma]Ping He, Yan Wang, Sheng Yang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 22, 2010
[A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients]Yan Sun, Hongsheng Lin, Yunzhong Zhu, et al.
Thoracic Cancer|April 18, 2019
Clinical features and outcomes of ALK rearranged non-small cell lung cancer with primary resistance to crizotinibDi Ma, Yan Zhang, Puyuan Xing, et al.
Frontiers in Pharmacology|March 25, 2022
Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase InhibitorsGuangjian Yang, Haiyan Xu, Jiaqi Hu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 30, 2019
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort studyPuyuan Xing, Di Ma, Qiang Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 25, 2016
[Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer]Sheng Yang, Yan Wang, Xingsheng Hu, et al.
Targeted Oncology|April 27, 2019
Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in ChinaPuyuan Xing, Shouzheng Wang, Qiang Wang, et al.
Pageof 11